Compare Infinitt North America vs Lifetrack Medical Systems
Customers evaluate the quality of Infinitt North America's products using the following success metrics.
Infinitt North America is 31 yrs old and is based in United States.
Infinitt develops image and information management technologies. Infinitt's web-based solution includes RIS, radiology PACS, cardiology PACS, mammography PACS, dental PACS, and 3D imaging capabilities on a single database, simplifying workflow, increasing system reliability, and reducing cost and support requirements.
Lifetrack Medical Systems is 12 yrs old and is based in Singapore.
Lifetrack Medical Systems is a Singapore and Philippines-based health tech startup that develops and deploys a scalable, fully distributed medical imaging software designed for affordable access for the two-thirds of the world’s population that currently lack it. The software has been used across Asia, North America, Europe, and Africa to allow customers to scale and integrate their radiology operations.
Mike Higgins (Chief Product Officer)
Information not available because Infinitt North America has not claimed their profile.
Work for Infinitt North America? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Infinitt North America?
Claim your profile now.
Why Lifetrack Medical Systems beats Infinitt North America
- Case turnaround times
- Patient studies processed
Hybrid, cloud, or on premise RIS/PACS solution that is zero footprint and can be remotely deployed.
Lifetrack Medical Systems works with 3 known companies.
Why They Buy
News & Analysis
Infinitt North America has not been mentioned in our research.
Lifetrack Medical Systems has been mentioned in our research 1 time.
Digital Health 150
The most promising digital health startups transforming the healthcare industry
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.